Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts.
Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Transplant Cell Ther. 2023 Dec;29(12):774.e1-774.e8. doi: 10.1016/j.jtct.2023.08.029. Epub 2023 Sep 4.
Patients who have undergone hematopoietic stem cell transplantation (HSCT) in childhood have a higher risk of diastolic heart failure (HF). The rate of progression of diastolic dysfunction in aging pediatric patients is unknown and is more difficult to assess in young patients secondary to changes in diastolic indices as they grow. HSCT recipients at our center were previously found to have decline in diastolic function indices at 1 year after HSCT. This study provides follow-up of this cohort, using age-normalized z-scores to assess whether the decline in diastolic function noted at 1-year post-HSCT persists, worsens, or improves over time. Patients age <21 years who underwent HSCT at Boston Children's Hospital/Dana-Farber Cancer Center between 2005 and 2008 with ≥3 surveillance echocardiograms, including 1 performed pre-HSCT, were included. Diastolic measures included mitral inflow (E/A ratio) and Doppler tissue imaging of left ventricular lateral wall (LV lateral e'), LV septal wall (septal e') and right ventricular free wall (RV e'). Systolic function was measured by LV ejection fraction (LVEF). Normalization by age was done using z-scores, and >±2 SD was defined as abnormal in linear modeling of diastolic dysfunction and systolic dysfunction over time. In a subset of patients with adequate post-HSCT images of the entire left atrium (LA), LA volume and LA strain analyses also were performed. The study cohort comprised 61 patients (41% female; median age at HSCT, 10.7 years; median follow-up, 7.4 years). Diastolic index z-scores declined by -.045/year for LV lateral e', -.06/year for LV septal e', and -.14/year for RV e' (P < .01). The E/A ratio z-score increased by .034/year (P = .028). Linear modeling demonstrated that LV lateral e' and LV septal e' would become abnormal at 25 and 20 years post-HSCT, respectively, whereas RV e' would become abnormal sooner, at 12.6 years. LVEF z-score declined by -.04/year (P < .01) and was estimated to become abnormal at 40 years post-HSCT. Exposure to total body irradiation (TBI) was associated with worsening diastolic indices, lower LVEF (P ≤ .002), and decreased LA reservoir strain (42.0% versus 45.0%; P = .016) and conduit strain (-31.5% versus -35.1%; P = .029), although there was significant overlap between TBI and anthracycline exposure. Treatment with anthracyclines even at low doses (median, 150 mg/m) was associated with declining LVEF but not with changes in diastolic indices. Long-term survivors of childhood HSCT exhibit declines in both LV and RV diastolic function indices. These results inform the rate of progression of LV and RV diastolic dysfunction indices over time in long-term survivors of pediatric HSCT. A significant association was observed between TBI and diastolic dysfunction and a decline in LVEF. Treatment with anthracyclines even at low doses was associated with a mild decline in LVEF. Our results can inform a lifespan perspective on disease management in this population, encourage clinicians and patients to be vigilant in following guideline-directed surveillance echocardiography, and inform anticipatory responses by clinicians as patients transition from pediatric care to adult care.
在儿童时期接受过造血干细胞移植 (HSCT) 的患者,患有舒张性心力衰竭 (HF) 的风险更高。衰老的儿科患者舒张功能障碍进展的速度尚不清楚,由于舒张指数随着儿童的生长而变化,因此在年轻患者中更难以评估。我们中心的 HSCT 受者在 HSCT 后 1 年发现舒张功能指数下降。本研究对该队列进行了随访,使用年龄标准化 z 分数来评估在 HSCT 后 1 年观察到的舒张功能下降是否持续、恶化或随时间改善。在波士顿儿童医院/丹娜-法伯癌症中心接受 HSCT 的患者年龄 <21 岁,接受 HSCT 的时间为 2005 年至 2008 年,且至少进行了 3 次监测超声心动图,其中包括 1 次在 HSCT 前进行。舒张测量包括二尖瓣血流(E/A 比值)和左心室侧壁的多普勒组织成像(LV 侧壁 e')、LV 间隔壁(间隔 e')和右心室游离壁(RV e')。通过 z 分数对左心室射血分数(LVEF)进行了标准化,在随时间变化的舒张功能和收缩功能的线性模型中,>±2 SD 被定义为异常。在有足够的 HSCT 后整个左心房(LA)图像的患者亚组中,还进行了 LA 容积和 LA 应变分析。研究队列包括 61 名患者(41%为女性;HSCT 时的中位年龄为 10.7 岁;中位随访时间为 7.4 年)。LV 侧壁 e'、LV 间隔 e'和 RV e'的舒张指数 z 分数分别每年下降-.045、-.06 和-.14(P<.01)。E/A 比值 z 分数每年增加.034(P=0.028)。线性模型表明,LV 侧壁 e'和 LV 间隔 e'将分别在 HSCT 后 25 年和 20 年变得异常,而 RV e'将更早,在 12.6 年变得异常。LVEF z 分数每年下降-.04(P<.01),预计在 HSCT 后 40 年变得异常。全身照射 (TBI) 的暴露与舒张指数恶化、LVEF 降低(P≤.002)以及 LA 储器应变降低(42.0%比 45.0%;P=0.016)和输送应变降低(-31.5%比-35.1%;P=0.029)相关,尽管 TBI 和蒽环类药物暴露之间存在显著重叠。即使接受低剂量(中位数 150mg/m)的蒽环类药物治疗,也与 LVEF 下降相关,但与舒张指数变化无关。接受儿童 HSCT 的长期幸存者表现出 LV 和 RV 舒张功能指数的下降。这些结果告知了儿科 HSCT 长期幸存者 LV 和 RV 舒张功能指数随时间的进展速度。TBI 与舒张功能障碍和 LVEF 下降之间存在显著相关性。即使接受低剂量的蒽环类药物治疗也与 LVEF 轻度下降有关。我们的结果可以为该人群的疾病管理提供终身视角,鼓励临床医生和患者警惕遵循指南指导的超声心动图监测,并为患者从儿科护理过渡到成人护理时,临床医生提供前瞻性响应。